Ribosomal RNA cleavage, nuclease activation and 2-5A(ppp(A2'p)nA) in interferon-treated cells
about
Activation of MDA5 requires higher-order RNA structures generated during virus infectionBasis for regulated RNA cleavage by functional analysis of RNase L and Ire1pA dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferonNew insights into the role of RNase L in innate immunityA new blotting medium for the simple isolation and identification of highly resolved messenger RNADiverse functions of RNase L and implications in pathologyA scientific journey through the 2-5A/RNase L systemViral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral responseActivation and evasion of the antiviral 2'-5' oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA.RNase L restricts the mobility of engineered retrotransposons in cultured human cellsRNase L targets distinct sites in influenza A virus RNAs.Structural insights into RNA duplexes with multiple 2΄-5΄-linkages.Endoribonuclease L (RNase L) regulates the myogenic and adipogenic potential of myogenic cellsViral phosphodiesterases that antagonize double-stranded RNA signaling to RNase L by degrading 2-5ARNase L mediates the antiviral effect of interferon through a selective reduction in viral RNA during encephalomyocarditis virus infectionSingle-strand-preferring nuclease activity in wheat leaves is increased in senescence and is negatively photoregulated.Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase LActivation of NF-kappaB by double-stranded RNA (dsRNA) in the absence of protein kinase R and RNase L demonstrates the existence of two separate dsRNA-triggered antiviral programsA transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase L.Murine AKAP7 has a 2',5'-phosphodiesterase domain that can complement an inactive murine coronavirus ns2 gene.Complementation of vaccinia virus lacking the double-stranded RNA-binding protein gene E3L by human cytomegalovirusAngiogenin abolishes cell-free protein synthesis by specific ribonucleolytic inactivation of ribosomes.RNase L interacts with Filamin A to regulate actin dynamics and barrier function for viral entryRibonuclease L and metal-ion-independent endoribonuclease cleavage sites in host and viral RNAs.Inhibition of RNase L and RNA-dependent protein kinase (PKR) by sunitinib impairs antiviral innate immunity.Structural requirements of (2'-5') oligoadenylate for protein synthesis inhibition in human fibroblastsNucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase LReversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene.Chemical synthesis and biological activities of analogues of 2',5'-oligoadenylates containing 8-substituted adenosine derivatives.A phylogenetically conserved RNA structure in the poliovirus open reading frame inhibits the antiviral endoribonuclease RNase L.Targets and intracellular signaling mechanisms for deoxynivalenol-induced ribosomal RNA cleavage.Alpha-interferon inhibits the expression of heavy chain mu messenger RNA in Daudi cells.Gene activity in primary T cells infected with HIV89.6: intron retention and induction of genomic repeats.RNase L Cleavage Products Promote Switch from Autophagy to Apoptosis by Caspase-Mediated Cleavage of Beclin-1.Immune responses to dsRNA: implications for gene silencing technologies.Regulation of p21/CIP1/WAF-1 mediated cell-cycle arrest by RNase L and tristetraprolin, and involvement of AU-rich elements.Immunological evidence for the in vivo occurrence of (2'-5')adenylyladenosine oligonucleotides in eukaryotes and prokaryotesRNase L triggers autophagy in response to viral infections.Expression of the E3L gene of vaccinia virus in transgenic mice decreases host resistance to vaccinia virus and Leishmania major infections.RNase L induces autophagy via c-Jun N-terminal kinase and double-stranded RNA-dependent protein kinase signaling pathways
P2860
Q24321400-E3AE9588-BE30-4CEC-99C8-C2CFD5503755Q24539965-4BF227F8-D8BB-44AE-AFAC-1011667C8A46Q24564476-AA148051-B80C-4887-98D3-C348092E469BQ24597466-538AA889-8481-445B-9451-C6BE0B9B39D0Q24635270-DB952D22-7D08-4B86-9074-1E160664CDBCQ24652347-166A50A3-BF23-46DE-8C98-A747F853ACE4Q24679551-49315BCB-4240-4241-8726-769390F9CABBQ24681387-EC98AB7E-CFC3-41AE-AADB-DCBFE4804942Q27472961-A9276BDE-B73B-4CAE-B003-08D3FA0E414CQ28660459-C626618A-5390-4C7C-AC62-D8D881ED8468Q30620296-3335417F-EF7B-4F99-9E42-E71DF20D8525Q30845087-3FDFE387-498B-41D1-8899-FBDCB8674853Q33511996-FC7076B4-A48A-47AE-B37F-B45D79A11167Q33714369-6DC2646A-0845-46B3-BFA6-699F0C3529DBQ33783019-C85B6822-CC15-45E6-8264-14893CFE90F5Q33852888-CB090484-E8BE-4163-B864-7ADD733A5107Q33887630-8CA5C600-B9D7-49B0-8997-CCC8240177B2Q33975105-E38F5929-1647-4BC1-A9E3-9B1AE894C8EFQ34055654-A392B882-E603-4F16-A81B-4FA0ACE8B52FQ34165352-0BA6FC5D-852D-4133-A877-652519C0D437Q34338614-DB07B364-9F9F-4189-B117-D9A6DE4CF04DQ34369878-1829D5F4-DFAC-4C6E-B558-57B5661DC8C9Q34440888-4849BDE4-A115-41AE-AADE-2D312BAECD44Q35087057-86004605-688D-4F66-9CF8-E4644DF5197FQ35128117-EC3F5423-B25A-40C4-B6F5-406A5AA1459CQ35499059-0BFB667A-15C4-4129-826D-0AF5B19B2753Q35620847-FF3468BB-F7A7-43A5-9034-8FBF514EEF43Q35830193-3D822D67-B13F-4F29-B0E0-CABE2DE7D587Q35853609-7A3481FD-632A-4F06-B84B-327652725743Q35857644-341EF409-BF17-42C5-833B-A554433DDCE8Q35969317-798D3506-599F-4331-B443-5BD49E2C9BF1Q36064251-65500B5D-87EF-44B9-BDED-6504A1C7A257Q36071452-1D611297-59B5-42EB-94F5-162F186BE832Q36088492-0B8FF29B-5A76-447C-9D3B-A2201CA89FD9Q36118482-9D616EB5-8EF0-4E17-A85E-249087F20848Q36228609-1685218A-B478-40D8-87B5-D8D67515E22DQ36256951-1E6122C9-C9AA-44AE-8A91-83AC143DA228Q36276209-A107CBA0-2C7F-449F-BD17-24A183AF05B8Q36423945-869F12E8-1379-4136-BB91-A75B011C95F6Q36481828-3D2881EE-3549-453F-AE2C-E0E17E660915
P2860
Ribosomal RNA cleavage, nuclease activation and 2-5A(ppp(A2'p)nA) in interferon-treated cells
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
1981年论文
@zh
1981年论文
@zh-cn
name
Ribosomal RNA cleavage, nuclea ...... A) in interferon-treated cells
@ast
Ribosomal RNA cleavage, nuclea ...... A) in interferon-treated cells
@en
type
label
Ribosomal RNA cleavage, nuclea ...... A) in interferon-treated cells
@ast
Ribosomal RNA cleavage, nuclea ...... A) in interferon-treated cells
@en
prefLabel
Ribosomal RNA cleavage, nuclea ...... A) in interferon-treated cells
@ast
Ribosomal RNA cleavage, nuclea ...... A) in interferon-treated cells
@en
P2093
P2860
P356
P1476
Ribosomal RNA cleavage, nuclea ...... A) in interferon-treated cells
@en
P2093
Silverman RH
Wreschner DH
P2860
P304
P356
10.1093/NAR/9.7.1571
P407
P577
1981-04-01T00:00:00Z